genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
CRISPR-Cas9 Goes Immuno-Incognito
News
University of California, U. Vienna, Charpentier Awarded Fourth U.S. CRISPR-Cas9 Patent
Artificial Intelligence
PTSD Diagnosed through Voice Analysis Using AI
News
Personalized, Combination Therapies Improve Cancer Patient Outcomes
News
Lilly, Avidity to Partner on Immunology Drugs in Up-to-$440M Collaboration
Insights
Insights
Urine-Based Liquid Biopsy for Nonurological Cancers
Insights
Top 10 Best-Selling Cancer Drugs of 2018
GWAS
Genetic Basis of Obesity Carries Weight
Insights
Liquid Biopsy: An Old Concept with a New Twist
CAR T-Cells
Preparing U.S. Healthcare Insurance for High-Cost Curative Therapies
A-Lists
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Insights
Top 10 Sequencing Companies
Insights
Top 10 Immuno-Oncology Collaborations
A-Lists
Top 15 Best-Selling Drugs of 2018
March 2019 Vol. 39 No. 3
Top 10 Immuno-Oncology Startups
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
CRISPR-Cas9 Goes Immuno-Incognito
News
University of California, U. Vienna, Charpentier Awarded Fourth U.S. CRISPR-Cas9 Patent
News
Personalized, Combination Therapies Improve Cancer Patient Outcomes
Insights
Urine-Based Liquid Biopsy for Nonurological Cancers
Magazine
April 2019 Vol. 39 No. 4
Functional Ultrasound
Commentary
Linear DNA Crosses the Line between Tags and Therapeutics
April 2019 Vol. 39 No. 4
Nucleic Acid Extraction: Extremely Fast, Extremely Simple, Extremely Effective
April 2019 Vol. 39 No. 4
CRISPR and Beyond: Advances in Gene Therapy
April 2019 Vol. 39 No. 4
Epigenetic Therapies Return Cells to the Straight and Narrow
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Upcoming Webinars
How to Decrease Long Read Sequencing Sample QC Time by 10-Fold
Videos
The First Computer-Generated Bacterial Genome
April 2019 Vol. 39 No. 4
Functional Ultrasound
Upcoming Webinars
De-Risky Business: Assessing Biotherapeutic Off-Target and On-Target Liabilities
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Translational Medicine
Transgenics
Transgenics
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Transgenics
Sangamo Offers to Sell 6.7M Shares of Common Stock
Transgenics
Ancient Genes Return, Put Evolutionary Hypotheses to the Test
Transgenics
Yecuris Introduces Humanized Mouse Knockout Model for In Vivo Hepatocyte Expansion
Transgenics
Means of Activating Latent Limb-Regenerating Genes Could Be Within Reach
Transgenics
Transgenic Cow Makes Hypoallergenic Milk
Transgenics
Horizon and Fox Chase Establish Gene-Editing Collaboration and Center of Excellence
Transgenics
Sangamo Offers to Sell 6.7M Shares of Common Stock
Transgenics
genOway Acquires Exclusive Rights to Rodent Engineering Platform from Bluebird Bio
Transgenics
Human Antibody Collaboration Launched
Transgenics
Taconic to Market Yecuris’ Humanized Animal Models
Transgenics
Ancient Genes Return, Put Evolutionary Hypotheses to the Test
Transgenics
Building a Better Mouse Model for Alzheimer’s
Transgenics
Suicide Cells in Tumor Environment Can Drive Metastasis
Transgenics
Symphogen and Origen Ally to Produce Transgenic Chickens
Transgenics
Designer Sperm Passes Selected Genes to Future Generations
1
2
3
4
Page 1 of 4
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Partners will use Horizon’s rAAV platform to generate mouse models and to investigate genetics of cancer drug resistance.[Gernot Krautberger-Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/April19_2011_2716446_FemSciCutsDNAScissors_HorizonFoxChaseGeneEditCollab8914417120-324x160.jpg "Horizon and Fox Chase Establish Gene-Editing Collaboration and Center of Excellence")
![Company has been leveraging ZFP and ZFN technology to develop research tools and therapeutics. [© Sergey Dashkevich - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/April8_2011_26427619_DollarsPieCharts_SangamoSellsStocks2061361012-324x160.jpg "Sangamo Offers to Sell 6.7M Shares of Common Stock")
![Company has been leveraging ZFP and ZFN technology to develop research tools and therapeutics. [© Sergey Dashkevich - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/April8_2011_26427619_DollarsPieCharts_SangamoSellsStocks2061361012.jpg "Sangamo Offers to Sell 6.7M Shares of Common Stock")
